Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Aug 08, 2018
SVP and Chief Legal Officer
SVP and Chief Legal Officer Open market or private sale of non-derivative or derivative security 437 $20.96
Jun 25, 2018
EVP, COO & CCO
EVP, COO & CCO Other acquisition or disposition -- --
Jun 25, 2018
EVP, COO & CCO
EVP, COO & CCO Open market or private sale of non-derivative or derivative security 235 $18.76
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
SVP and Chief Legal Officer
SVP and Chief Legal Officer Other acquisition or disposition -- --
Jun 18, 2018
SVP and Chief Legal Officer
SVP and Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 45,000 --
Jun 18, 2018
SVP and Chief Legal Officer
SVP and Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 110,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
May 22, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 40,000 $1.47
May 22, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 40,000 --
May 17, 2018
Director
Director Open market or private sale of non-derivative or derivative security 21,113 $18.94
May 17, 2018
Director
Director Other acquisition or disposition -- --
May 17, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 112,500 $1.43

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.